Summary
- Current Price
- As of today, FENC price is $6.41, up +4.23% on
- Current Price All-Time High
- FENC price is currently -57.23% below its historical high of $14.99 set on
- Market Cap
- FENC current market cap is $219M, up +43.47% over the past 365 days
- PE Ratio
- FENC PE ratio is unknown
- Revenue
- FENC current annual revenue is $44.64M, down -6.09% year-over-year
- Next Earnings
- The next earnings release for FENC is on
Profile
| Metric | Value |
|---|---|
| Full Name | Fennec Pharmaceuticals Inc. |
| Ticker | NASDAQ: FENC |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | fennecpharma.com |
| Employees | 32 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $6.41 | ||
| Price, 1D Change | +4.23% | |
| $219M | ||
| - | ||
| - | ||
| 0.96 | ||
| $45M | ||
| Revenue, 1Y Change | -6.09% | |
| -$0.35 | ||
| EPS, 1Y Change | -2,108.75% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:3 | |
| Next Split | N/A | N/A |
| Last Ticker Change | ADH | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.35 | ||
| EPS Estimate | N/A | $0.20 |
| EPS Est. Change | N/A | +156.59% |
| $44.64M | ||
| Revenue Estimate | N/A | $70.75M |
| Revenue Est. Change | N/A | +58.49% |
| $6.41 | ||
| Price Target | - | $15.50 |
| Price Tgt. Change | - | +141.81% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.09 | -$0.02 | +81.55% | |
| -$0.13 | -$0.35 | -167.73% | |
| $0.20 | N/A | +156.59% | |
| $0.89 | N/A | +352.97% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $56.05M | $47.54M | -15.19% | |
| $45.60M | $44.64M | -2.10% | |
| $70.75M | N/A | +58.49% | |
| $104.19M | N/A | +133.38% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +15.91% | ||
| -22.96% | ||
| +43.47% | ||
| -0.37% | ||
| -6.09% | ||
| +2,808.27% | ||
| -2,108.75% | ||
| +60.84% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $6.41 | ||
| $8.19 | ||
| SMA 200 vs Price | +27.77% | |
| $7.73 | ||
| SMA 50 vs Price | +20.64% | |
| 0.96 | ||
| $0.51 | ||
| 40.05 | ||
| 126.30% | ||
| 54.02% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $44.64M | ||
| -$0.35 | ||
| $40.88M | ||
| 91.57% | ||
| -$6.74M | ||
| -15.11% | ||
| -$10.10M | ||
| -22.62% | ||
| -$6.28M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 6.34 | ||
| 6.19 | ||
| - | ||
| 2 | ||
| 0.44 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 4.90 | ||
| 6.23 | ||
| -27.00 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $35.12M | ||
| $36.79M | ||
| $70.19M | ||
| $66.69M | ||
| $35.08M | ||
| $10.52M | ||
| $0.00 | ||
| $0.00 | ||
| $4.64M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $54.74M | ||
| $47.62M | ||
| $3.76M | ||
| $0.00 | ||
| - | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$14.42M | ||
| $0.00 | ||
| $24.58M | ||
| $0.00 | ||
| -$14.42M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Piper Sandler | ||
| HC Wainwright & Co. | → | |
| Craig-Hallum | → | |
| HC Wainwright & Co. | → | |
| Craig-Hallum | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Craig-Hallum | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with FENC
FAQ
What is the ticker symbol for Fennec Pharmaceuticals Inc.?
The ticker symbol for Fennec Pharmaceuticals Inc. is NASDAQ:FENC
Does Fennec Pharmaceuticals Inc. pay dividends?
No, Fennec Pharmaceuticals Inc. does not pay dividends
What sector is Fennec Pharmaceuticals Inc. in?
Fennec Pharmaceuticals Inc. is in the Healthcare sector
What industry is Fennec Pharmaceuticals Inc. in?
Fennec Pharmaceuticals Inc. is in the Biotechnology industry
What country is Fennec Pharmaceuticals Inc. based in?
Fennec Pharmaceuticals Inc. is headquartered in United States
When did Fennec Pharmaceuticals Inc. go public?
Fennec Pharmaceuticals Inc. initial public offering (IPO) was on September 15, 2017
Is Fennec Pharmaceuticals Inc. in the S&P 500?
No, Fennec Pharmaceuticals Inc. is not included in the S&P 500 index
Is Fennec Pharmaceuticals Inc. in the NASDAQ 100?
No, Fennec Pharmaceuticals Inc. is not included in the NASDAQ 100 index
Is Fennec Pharmaceuticals Inc. in the Dow Jones?
No, Fennec Pharmaceuticals Inc. is not included in the Dow Jones index
When was Fennec Pharmaceuticals Inc. last earnings report?
Fennec Pharmaceuticals Inc.'s most recent earnings report was on November 13, 2025
When does Fennec Pharmaceuticals Inc. report earnings?
The next expected earnings date for Fennec Pharmaceuticals Inc. is May 12, 2026
Data Sources & References
- FENC Official Website fennecpharma.com
- FENC Profile on Yahoo Finance finance.yahoo.com/quote/FENC
- FENC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/fenc